Holen Sie sich die Stockscreener-App
115.49
8.69%
-10.99
Handel nachbörslich:
115.70
0.21
+0.18%
Schlusskurs vom Vortag:
$126.48
Offen:
$125.1
24-Stunden-Volumen:
3.84M
Relative Volume:
2.59
Marktkapitalisierung:
$9.06B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-159.39M
KGV:
-32.62
EPS:
-3.5401
Netto-Cashflow:
$-105.22M
1W Leistung:
-14.36%
1M Leistung:
+0.38%
6M Leistung:
+1,390%
1J Leistung:
+1,629%
1-Tages-Spanne:
$108.95
$125.10
1-Wochen-Bereich:
$108.95
$138.69
52-Wochen-Spanne:
$4.77
$148.83
Abivax Adr Stock (ABVX) Company Profile
Vergleichen Sie ABVX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABVX
Abivax Adr
|
115.49 | 9.92B | 0 | -159.39M | -105.22M | -3.5401 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Abivax Adr Stock (ABVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Eingeleitet | Truist | Buy |
| 2025-11-06 | Eingeleitet | Wolfe Research | Outperform |
| 2025-10-13 | Eingeleitet | Barclays | Overweight |
| 2025-07-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-03-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-12-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-07-29 | Eingeleitet | Laidlaw | Buy |
| 2024-05-20 | Eingeleitet | BTIG Research | Buy |
| 2024-04-29 | Eingeleitet | Guggenheim | Buy |
| 2024-04-29 | Eingeleitet | Piper Sandler | Overweight |
| 2023-11-14 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-14 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Abivax Adr Aktie (ABVX) Neueste Nachrichten
Is ABIVAX Societe Anonyme (ABVX) One of the Hottest Large-Cap Stocks of 2025? - Finviz
Could This Potential Move Boost Eli Lilly's Prospects? - Finviz
Voya Investment Management LLC Invests $978,000 in Abivax SA Sponsored ADR $ABVX - MarketBeat
61,449 Shares in Abivax SA Sponsored ADR $ABVX Purchased by Simplify Asset Management Inc. - MarketBeat
Abivax (NASDAQ:ABVX) Shares Gap UpHere's What Happened - MarketBeat
Guggenheim Bullish on Abivax (ABVX) Ahead of Key Obefazimod Data Readout - Finviz
Abivax (NASDAQ:ABVX) Trading Up 6%Time to Buy? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX) and Integra Lifesciences (IART) - The Globe and Mail
Abivax (NASDAQ:ABVX) Sets New 1-Year HighHere's Why - MarketBeat
Why Abivax Stock Was on Fire Today - Finviz
Why Abivax Stock Was on Fire Today - The Motley Fool
Why Abivax SA Sponsored ADR Shares Are Tumbling - TipRanks
Abivax SA Sponsored ADR (NASDAQ:ABVX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Abivax shares gain after 22 scientific abstracts accepted for ECCO 2026 - MSN
Abivax stock rises after announcing acceptance of 22 abstracts at ECCO 2026 - Investing.com
Analysts Are Bullish on These Healthcare Stocks: Nuvalent (NUVL), Novan (NOVN) - The Globe and Mail
Abivax SA Sponsored ADR (ABVX) Receives a Buy from Truist Financial - The Globe and Mail
symbol__ Stock Quote Price and Forecast - CNN
Citizens Jmp Issues Positive Forecast for Abivax (NASDAQ:ABVX) Stock Price - Defense World
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers - ts2.tech
Abivax (NASDAQ:ABVX) Trading Down 5.9%Should You Sell? - MarketBeat
Abivax SA Reports Increased Losses in Q3 2025 Amid Rising R&D Costs - TipRanks
FY2025 EPS Estimates for Abivax Decreased by Lifesci Capital - MarketBeat
A Look at Abivax ADR (ABVX) Shares in the Recent Past Indicates Growth - setenews.com
Stempoint Capital LP Invests $671,000 in Abivax SA Sponsored ADR $ABVX - MarketBeat
Abivax Sees Unusually Large Options Volume (NASDAQ:ABVX) - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Acquired by Kennedy Capital Management LLC - MarketBeat
Abivax SA Sponsored ADR $ABVX Shares Sold by Affinity Asset Advisors LLC - MarketBeat
A3EWCP Stock Price and Chart — LSX:A3EWCP - TradingView — Track All Markets
Abivax SA Sponsored ADR $ABVX Shares Bought by Saturn V Capital Management LP - MarketBeat
Quadrature Capital Ltd Acquires Shares of 19,367 Abivax SA Sponsored ADR $ABVX - MarketBeat
Investors in cash trouble should check out Abivax ADR (ABVX) - setenews.com
Optimistic Buy Rating for Abivax SA: Potential of Obefazimod Amid Safety and Financial Considerations - TipRanks
Abivax SA Sponsored ADR Dividends – LS:A3EWCP - TradingView
ETFs Investing in Abivax SA Sponsored ADR Stocks - TradingView
There is no doubt that Abivax ADR (ABVX) ticks all the boxes. - Setenews
Abivax SA Sponsored ADR (ABVX) Receives a New Rating from Truist Financial - The Globe and Mail
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Rating of “Buy” from Analysts - Defense World
Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Average Rating of "Buy" from Analysts - MarketBeat
Abivax (NASDAQ:ABVX) Sees Large Volume IncreaseHere's Why - MarketBeat
Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025 - ts2.tech
Is Abivax ADR (ABVX) positioned for future growth? - Setenews
Nothing is Better Than Kyivstar Group Ltd (KYIV) stock at the moment - Setenews
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fate Therapeutics (FATE), ALX Oncology Holdings (ALXO) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
Abivax (NASDAQ:ABVX) Sets New 12-Month HighStill a Buy? - MarketBeat
Abivax (NASDAQ:ABVX) Sees Strong Trading VolumeStill a Buy? - MarketBeat
Abivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's What You Should Know - MSN
Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI) and Cellectar Biosciences (CLRB) - The Globe and Mail
Are Medical Stocks Lagging Abivax SA Sponsored ADR (ABVX) This Year? - sharewise.com
A new trading data show Abivax ADR (ABVX) is showing positive returns. - Setenews
Akebia Therapeutics (AKBA) Receives a Buy from BTIG - The Globe and Mail
Finanzdaten der Abivax Adr-Aktie (ABVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):